Intended for healthcare professionals

News

Microdosing mushroom sweet treats are recalled in US after six hospital admissions and two potential deaths

BMJ 2024; 386 doi: https://doi.org/10.1136/bmj.q1871 (Published 27 August 2024) Cite this as: BMJ 2024;386:q1871
  1. Ingrid Torjesen
  1. London

All products of a brand of microdosing, mushroom infused confectionery called Diamond Shruumz that are available in the US have been recalled and withdrawn from sale after they were linked to 145 illnesses across 29 states, including 59 hospital admissions and two potential deaths.

Diamond Shruumz produces a range of chocolate bars, cones, and gummies that it markets as “an artisan treat for the alternative set.” The confectionery contains a “primo proprietary blend of nootropic and functional mushrooms,” which …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription